5-129461108-A-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_133638.6(ADAMTS19):c.98A>T(p.Gln33Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000169 in 1,412,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133638.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS19 | NM_133638.6 | c.98A>T | p.Gln33Leu | missense_variant | 2/23 | ENST00000274487.9 | NP_598377.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS19 | ENST00000274487.9 | c.98A>T | p.Gln33Leu | missense_variant | 2/23 | 1 | NM_133638.6 | ENSP00000274487.5 | ||
ADAMTS19 | ENST00000505791.5 | n.91+626A>T | intron_variant | 3 | ENSP00000423537.2 | |||||
ADAMTS19-AS1 | ENST00000661962.1 | n.-32T>A | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000177 AC: 1AN: 56432Hom.: 0 AF XY: 0.0000304 AC XY: 1AN XY: 32864
GnomAD4 exome AF: 0.000181 AC: 228AN: 1260732Hom.: 0 Cov.: 30 AF XY: 0.000181 AC XY: 112AN XY: 619904
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74346
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.80A>T (p.Q27L) alteration is located in exon 2 (coding exon 2) of the ADAMTS19 gene. This alteration results from a A to T substitution at nucleotide position 80, causing the glutamine (Q) at amino acid position 27 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at